Iressa 2nd Line Phase III Study in Japan

Clinical trial NCT00252707 · COMPLETED

Trial details

NCT number: NCT00252707
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2003-09-01
Enrollment: 484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.